Kurzrock R - Search Results

1

Turmeric and green tea: a recipe for the treatment of B-chronic lymphocytic leukemia.

Angelo LS, Kurzrock R. Angelo LS, et al. Among authors: kurzrock r. Clin Cancer Res. 2009 Feb 15;15(4):1123-5. doi: 10.1158/1078-0432.CCR-08-2791. Clin Cancer Res. 2009. PMID: 19228716 Free PMC article.

2

Bone marrow hypoplasia and aplasia complicating interferon therapy for chronic myelogenous leukemia.

Talpaz M, Kantarjian H, Kurzrock R, Gutterman JU. Talpaz M, et al. Among authors: kurzrock r. Cancer. 1992 Jan 15;69(2):410-2. doi: 10.1002/1097-0142(19920115)69:2<410::aid-cncr2820690222>3.0.co;2-v. Cancer. 1992. PMID: 1370212

3

Interferon-stimulated genes in interferon-sensitive and -resistant chronic myelogenous leukemia patients.

Talpaz M, Chernajovsky Y, Troutman-Worden K, Wetzler M, Kantarjian H, Gutterman JU, Kurzrock R. Talpaz M, et al. Among authors: kurzrock r. Cancer Res. 1992 Mar 1;52(5):1087-90. Cancer Res. 1992. PMID: 1737366

4

Therapy of chronic myelogenous leukemia with interferon.

Kurzrock R, Gutterman JU, Kantarjian H, Talpaz M. Kurzrock R, et al. Cancer Invest. 1989;7(1):83-91. doi: 10.3109/07357908909038270. Cancer Invest. 1989. PMID: 2472193 No abstract available.

5

Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha.

Wetzler M, Estrov Z, Talpaz M, Kim KJ, Alphonso M, Srinivasan R, Kurzrock R. Wetzler M, et al. Among authors: kurzrock r. Cancer Res. 1994 Apr 1;54(7):1837-42. Cancer Res. 1994. PMID: 8137298

6

Biological properties and growth in SCID mice of a new myelogenous leukemia cell line (KBM-5) derived from chronic myelogenous leukemia cells in the blastic phase.

Beran M, Pisa P, O'Brien S, Kurzrock R, Siciliano M, Cork A, Andersson BS, Kohli V, Kantarjian H. Beran M, et al. Among authors: kurzrock r. Cancer Res. 1993 Aug 1;53(15):3603-10. Cancer Res. 1993. PMID: 8339266

7

Transformation of chronic lymphocytic leukemia to lymphoma of true histiocytic type.

Wetzler M, Kurzrock R, Goodacre AM, McLaughlin P, Ku S, Talpaz M. Wetzler M, et al. Among authors: kurzrock r. Cancer. 1995 Aug 15;76(4):609-17. doi: 10.1002/1097-0142(19950815)76:4<609::aid-cncr2820760411>3.0.co;2-y. Cancer. 1995. PMID: 8625154 Review.

8

Z-138: a new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemia.

Estrov Z, Talpaz M, Ku S, Harris D, Van Q, Beran M, Hirsch-Ginsberg C, Huh Y, Yee G, Kurzrock R. Estrov Z, et al. Among authors: kurzrock r. Leuk Res. 1998 Apr;22(4):341-53. doi: 10.1016/s0145-2126(97)00191-4. Leuk Res. 1998. PMID: 9669839

9

Chronic myelogenous leukemia--progress at the M. D. Anderson Cancer Center over the past two decades and future directions: first Emil J Freireich Award Lecture.

Kantarjian HM, Talpaz M, O'Brien S, Kurzrock R, Gutterman J, Keating MJ, McCredie KB, Freireich EJ. Kantarjian HM, et al. Among authors: kurzrock r. Clin Cancer Res. 1997 Dec;3(12 Pt 2):2723-33. Clin Cancer Res. 1997. PMID: 10068280 Review.

10

RAS and leukemia: from basic mechanisms to gene-directed therapy.

Beaupre DM, Kurzrock R. Beaupre DM, et al. Among authors: kurzrock r. J Clin Oncol. 1999 Mar;17(3):1071-9. doi: 10.1200/JCO.1999.17.3.1071. J Clin Oncol. 1999. PMID: 10071302 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,016 results

Search Page

Filters